Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - dennis discher
Selective phagocytosis of human cancer cells as target for immunotherapy
Cell therapy based methods to reduce tumor growth by disrupting the CD47-SIRPα interaction and targeting cells for phagocytosis with antibodies. Problem: Current cancer treatments (i.e. radiation, chemotherapy, etc.) result in multiple serious side effects due to lack of treatment specificity. Cancer immunotherapies in development target...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by